Compositions and methods for inhibiting expression of glucocorticoid receptor (GCR) genes

Details for Australian Patent Application No. 2010247389 (hide)

Owner F. Hoffmann-La Roche AG

Inventors Bailly, Jacques; Benardeau, Agnes; Bramlage, Birgit; Constien, Rainer; Forst, Andrea; Hossbach, Markus; Schott, Brigitte

Agent Spruson & Ferguson

Pub. Number AU-A-2010247389

PCT Pub. Number WO2010/130771

Priority 09160411.6 15.05.09 EP

Filing date 12 May 2010

Wipo publication date 18 November 2010

International Classifications

A61P 3/04 (2006.01) Drugs for disorders of the metabolism

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

C12N 15/113 (2010.01) Mutation or genetic engineering - Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides

Event Publications

27 October 2011 PCT application entered the National Phase

  PCT publication WO2010/130771 Priority application(s): WO2010/130771

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2010247391-Benzoxazolone derivatives as aldosterone symthase inhibitors

2010247385-Fungicide pyrazole carboxamides derivatives